Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

fMRI Can Help Diagnose Fibromyalgia

David C. Holzman  |  Issue: March 2017  |  March 20, 2017

“We’d need a large clinical trial to prove that these changes we see are driving the pain,” says Dr. Harris. Such a trial would require scanning a group of subjects lacking chronic pain, to see which ones nonetheless had neural signatures of fibromyalgia. They would then have to be followed for at least two, and maybe as much as 10 years to see if significant numbers developed the pain. Then, if the findings showed that the pathology predated the pain, it would be possible to say that the neuroimaging results were not a consequence of the pain, he says.

The alternative hypothesis—supported by “some in the field,” says Dr. Harris, is that some chronic pain conditions— possibly including fibromyalgia—have a “peripheral generator.” Osteoarthritis inflammation or nerve damage in stroke—to name two of multiple possibilities—could send pain signals into the brain, he says. Those who favor the peripheral generator posit that the persistence of peripheral pain information coming into the central nervous system could cause the increase in pain, says Dr. Harris.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Benefits of the Research

The most immediate benefit for patients is that the imaging demonstrates the oft-denied reality of their symptoms, “providing them with an objective finding, a data point that says they have a real condition, which implies they can be treated,” says Dr. Harris.

If the research is validated, it likely will also become possible to use fMRI to determine which patients will respond to pain medication. Pain medications work on only about 30% of pain patients, including roughly that fraction of fibro­myalgia patients, says Dr. Harris. The pattern of activity in the brain—which brain regions are active or inactive at the same time—may be able to predict treatment response, he says. That would save money and time for both patients and doctors.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Other benefits may accrue to patients with pains that are generally assumed to be specific to a body part, such as osteoarthritis in a knee or pelvic pain in women, rather than generalized, as in fibromyalgia. The problem is that sometimes excising the peripheral body part, such as with knee replacement or hysterectomy, occasionally fails to cure the pain, potentially because the pain is generated in the brain. And physicians frequently don’t take a thorough history regarding pain symptoms. “Very rarely do they assess how widespread the pain is,” says Dr. Harris. “Do they have pain in other areas? Do they have these other types of disorders that co‑aggregate with fibromyalgia?”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsPain SyndromesTechnology Tagged with:brainDiagnosisFibromyalgiafMRIimagingmachine learningPainrheumatologistrheumatologystimuli

Related Articles

    fMRI Provides Visual Evidence of Pain

    January 1, 2015

    Functional MRI scans that show how pain changes the brain could help rheumatologists develop better approaches to pain relief

    Neurological Piece of the Fibromyalgia Puzzle

    November 1, 2009

    Exploring the peripheral and central elements of pain in FM

    Turn Down the Pain Volume

    October 1, 2009

    Fibromyalgia’s evolution from discrete entity to prototypical central pain syndrome

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences